Results 21 to 30 of about 256 (86)

The myasthenic patient in crisis: an update of the management in Neurointensive Care Unit

open access: yesArquivos de Neuro-Psiquiatria, 2013
Myasthenia gravis (MG) is an autoimmune disorder affecting neuromuscular transmission leading to generalized or localized muscle weakness due most frequently to the presence of autoantibodies against acetylcholine receptors in the postsynaptic motor end ...
Daniel Agustin Godoy   +3 more
doaj   +1 more source

Mejoras en la calidad de vida de los pacientes con Miastenia Gravis sin timoma intervenidos con timectomía videotoracoscópica

open access: yesMaskana, 2019
La Timectomía es parte del tratamiento de la Miastenia Gravis debido a que puede producir remisiones de la sintomatología. Los parámetros que determinan el éxito de la cirugía son únicamente cuantitativos: cantidad de medicación o presencia/ausencia de ...
Nathalie Pinos, Miguel Congregado
doaj   +1 more source

Myasthenic crisis: report of 24 cases Crise miastênica: relato de 24 casos

open access: yesArquivos de Neuro-Psiquiatria, 2002
Myasthenic crisis (MC) is a life-threatening complication of myasthenia gravis (MG) with a high mortality rate. The aim of our study was to review the different therapeutics approaches in the treatment of MC and their impact in the final outcome.
Lineu Cesar Werneck   +4 more
doaj   +1 more source

Ruolo della timectomia nel trattamento della miastenia gravis: considerazioni e casistica personale [PDF]

open access: yes, 2003
L’effetto terapeutico della timectomia sul decorso clinico della miastemia gravis è ancora quanto mai controverso. Infatti, mentre la chirurgia è ormai universalmente accettata per i timomi, il suo ruolo è ancora discutibile in pazienti con miastenia ...
Micali, Vincenzo   +9 more
core   +1 more source

Myasthenia gravis and thymoma: evaluation of 41 patients Miastenia grave e timoma: avaliação de 41 pacientes

open access: yesArquivos de Neuro-Psiquiatria, 1999
We evaluated the epidemiological, clinical, laboratory and therapeutical aspects of 41 patients with thymomatous myasthenia gravis. Thirty five patients (85.36%) were submitted to thymectomy. Follow-up ranged from two to 18 years.
JOSÉ LAMARTINE DE ASSIS   +3 more
doaj   +1 more source

Perioperative challenges and neuromuscular blockade concerns in robotic thymectomy for myasthenia gravis

open access: yesBrazilian Journal of Anesthesiology, 2020
Myasthenia Gravis (MG) is an autoimmune disease characterized by weakness and fatigability of skeletal muscles, with improvement following rest. It is a disease of great significance to the anesthesiologist because it affects the neuromuscular junction ...
Atish Pal, Vikas Gogia, Chetan Mehra
doaj   +1 more source

Results of surgical treatment for juvenile myasthenia gravis

open access: yesNeurología (English Edition), 2017
Introduction: Radical or extended thymectomy is an effective treatment for myasthenia gravis in the adult population. There are few reports to demonstrate the effectiveness of this treatment in patients with juvenile myasthenia gravis.
F.J. Vázquez-Roque   +5 more
doaj   +1 more source

Resultados del tratamiento quirúrgico en la miastenia gravis juvenil

open access: yesNeurología, 2017
Resumen: Introducción: La timectomía radical ampliada para el tratamiento de la miastenia gravis es una opción efectiva en la población adulta. No ocurre lo mismo en el caso de la miastenia gravis juvenil, ya que existen pocos reportes que demuestren su
F.J. Vázquez-Roque   +5 more
doaj   +1 more source

Pericardite constritiva: relato de caso / Constrictive pericarditis: case report [PDF]

open access: yes, 2022
A pericardite constritiva se desenvolve a partir de um espessamento fibroso do pericárdio, sendo o estágio final de um processo inflamatório que envolve suas diferentes camadas.
Rebello, Loren Rosetti   +2 more
core  

Síntomas de miastenia grave en un paciente con antecedente de timectomía por timoma invasor

open access: yesBiomédica: revista del Instituto Nacional de Salud, 2015
Introducción. La miastenia grave es una enfermedad autoinmunitaria mediada por anticuerpos. Entre 10 y 15 % de quienes la padecen tienen timoma y su presencia se asocia con una mayor gravedad de los síntomas, crisis miasténicas y fracaso del tratamiento ...
Lilliana María Giraldo   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy